A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled AZD2115 After Single Ascending Doses in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 17 Aug 2011
At a glance
- Drugs AZD 2115 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 17 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Aug 2011 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 20 Feb 2011 New trial record